Merck Healthcare Kgaa, Darmstadt, Germany, An Affiliate Of Merck Kgaa, Darmstadt, Germany

This early-stage study tests a new drug called M9140 in 12 Chinese adults with advanced colorectal cancer that has not responded to standard treatments. The drug is designed to target and kill cancer cells while limiting harm to healthy cells. The main goals are to check safety a…

This study looks at the long-term safety of the drug enpatoran in people with lupus who have already finished a 24-week treatment in a previous study. About 379 participants will take the drug by mouth to see how well it controls their disease over time. The goal is to monitor si…

This study follows 367 adults with relapsing multiple sclerosis (RMS) who are taking cladribine tablets. Researchers want to find out which patient traits predict how well the drug works and how safe it is over time. The main goal is to see how long people stay on treatment, and …

This study reviews medical records of 360 Japanese patients with advanced bladder cancer who received avelumab as a maintenance treatment after initial chemotherapy. The goal is to understand patient characteristics, treatment patterns, and outcomes like survival and tumor respon…